Search Page

1

Cite

Share

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.

Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, Pizarro A, Acevedo J, Leo K, Leon F, Sans C, Leighton P, Suárez P, García-Escorza H, Araos R. Jara A, et al. Among authors: araos r. N Engl J Med. 2021 Sep 2;385(10):875-884. doi: 10.1056/NEJMoa2107715. Epub 2021 Jul 7. N Engl J Med. 2021. PMID: 34233097 Free PMC article.

Cite

Share

2

Cite

Share

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.

Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O'Brien KL, Smith PG, Wilder-Smith A, Zeger S, Deloria Knoll M, Patel MK. Feikin DR, et al. Among authors: araos r. Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23. Lancet. 2022. PMID: 35202601 Free PMC article.

Cite

Share

3

Cite

Share

Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples.

Porte L, Legarraga P, Vollrath V, Aguilera X, Munita JM, Araos R, Pizarro G, Vial P, Iruretagoyena M, Dittrich S, Weitzel T. Porte L, et al. Among authors: araos r. Int J Infect Dis. 2020 Oct;99:328-333. doi: 10.1016/j.ijid.2020.05.098. Epub 2020 Jun 1. Int J Infect Dis. 2020. PMID: 32497809 Free PMC article.

Cite

Share

4

Cite

Share

The human microbiota and infection prevention.

Araos R, D'Agata EMC. Araos R, et al. Infect Control Hosp Epidemiol. 2019 May;40(5):585-589. doi: 10.1017/ice.2019.28. Epub 2019 Feb 19. Infect Control Hosp Epidemiol. 2019. PMID: 30777586 Review.

Cite

Share

5

Cite

Share

The story behind Chile's rapid rollout of COVID-19 vaccination.

Aguilera X, Mundt AP, Araos R, Weitzel T. Aguilera X, et al. Among authors: araos r. Travel Med Infect Dis. 2021 Jul-Aug;42:102092. doi: 10.1016/j.tmaid.2021.102092. Epub 2021 May 27. Travel Med Infect Dis. 2021. PMID: 34051353 Free PMC article. No abstract available.

Cite

Share

6

Cite

Share

Effectiveness of an Inactivated SARS-CoV-2 Vaccine. Reply.

Jara A, Undurraga EA, Araos R. Jara A, et al. Among authors: araos r. N Engl J Med. 2021 Sep 30;385(14):1338-1339. doi: 10.1056/NEJMc2112423. Epub 2021 Sep 15. N Engl J Med. 2021. PMID: 34525281 No abstract available.

Cite

Share

7

Cite

Share

Human Colonization With Multidrug-Resistant Organisms: Getting to the Bottom of Antibiotic Resistance.

Smith RM, Lautenbach E, Omulo S, Araos R, Call DR, Kumar GCP, Chowdhury F, McDonald CL, Park BJ. Smith RM, et al. Among authors: araos r. Open Forum Infect Dis. 2021 Oct 17;8(11):ofab531. doi: 10.1093/ofid/ofab531. eCollection 2021 Nov. Open Forum Infect Dis. 2021. PMID: 34805441 Free PMC article. No abstract available.

Cite

Share

8

Cite

Share

Acquisition of Multidrug-resistant Organisms in the Absence of Antimicrobials.

D'Agata EMC, Varu A, Geffert SF, Araos R, Mitchell S, Situ A, Cameron C. D'Agata EMC, et al. Among authors: araos r. Clin Infect Dis. 2018 Oct 15;67(9):1437-1440. doi: 10.1093/cid/ciy358. Clin Infect Dis. 2018. PMID: 29697767 Free PMC article.

Cite

Share

9

Cite

Share

Tool for Estimating the Probability of Having COVID-19 With 1 or More Negative RT-PCR Results.

Jara A, Undurraga EA, Araos R. Jara A, et al. Among authors: araos r. Open Forum Infect Dis. 2021 Jul 16;8(8):ofab382. doi: 10.1093/ofid/ofab382. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34395714 Free PMC article.

Cite

Share

10

Cite

Share

Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium.

Weitzel T, Legarraga P, Iruretagoyena M, Pizarro G, Vollrath V, Araos R, Munita JM, Porte L. Weitzel T, et al. Among authors: araos r. Travel Med Infect Dis. 2021 Jan-Feb;39:101942. doi: 10.1016/j.tmaid.2020.101942. Epub 2020 Dec 2. Travel Med Infect Dis. 2021. PMID: 33278609 Free PMC article. No abstract available.

Cite

Share